BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 27543391)

  • 1. A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models.
    Li X; Chen G; Zhang X; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4241-5. PubMed ID: 27476422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-proliferative effect and induction of apoptosis in androgen-independent human prostate cancer cells by 1,5-bis(2-hydroxyphenyl)-1,4-pentadiene-3-one.
    Citalingam K; Abas F; Lajis NH; Othman I; Naidu R
    Molecules; 2015 Feb; 20(2):3406-30. PubMed ID: 25690296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.
    Vue B; Zhang X; Lee T; Nair N; Zhang S; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem; 2017 Sep; 25(17):4845-4854. PubMed ID: 28756013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of 2-(naphthalen-1-yloxy)-N-phenylacetamide derivatives as TRPM4 inhibitors for the treatment of prostate cancer.
    Niu L; Liu H; Li X; Wang L; Hua H; Cao Q; Xiang Q; Cai T; Zhu D
    Bioorg Med Chem; 2024 Jan; 98():117584. PubMed ID: 38168629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic activity and cell cycle analysis of hexahydrocurcumin on SW 480 human colorectal cancer cells.
    Chen CY; Yang WL; Kuo SY
    Nat Prod Commun; 2011 Nov; 6(11):1671-2. PubMed ID: 22224285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin glucuronides: assessing the proliferative activity against human cell lines.
    Pal A; Sung B; Bhanu Prasad BA; Schuber PT; Prasad S; Aggarwal BB; Bornmann WG
    Bioorg Med Chem; 2014 Jan; 22(1):435-9. PubMed ID: 24280069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of cyclic C7-bridged monocarbonyl curcumin analogs containing an
    Gan X; Wu Y; Zhu M; Liu B; Kong M; Xi Z; Li K; Wang H; Su T; Yao J; Khushafah F; Yi B; Wang J; Li W; Wu J
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2314233. PubMed ID: 38385332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of curcumin and ursolic acid in prostate cancer: A systematic review.
    Besasie BD; Saha A; DiGiovanni J; Liss MA
    Urologia; 2024 Feb; 91(1):90-106. PubMed ID: 37776274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Review on Recent Strategies for Management of Prostate Cancer: Therapeutic Targets and SAR.
    Chaudhary M; Kumar S; Kaur P; Sahu SK; Mittal A
    Mini Rev Med Chem; 2024; 24(7):721-747. PubMed ID: 37694781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.
    Zhang X; Guo S; Chen C; Perez GR; Zhang C; Patanapongpibul M; Subrahmanyam N; Wang R; Keith J; Chen G; Dong Y; Zhang Q; Zhong Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2017 Sep; 137():263-279. PubMed ID: 28601720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models.
    Wang R; Zhang X; Chen C; Chen G; Sarabia C; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2017 Jun; 133():208-226. PubMed ID: 28388523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.
    Wang R; Chen C; Zhang X; Zhang C; Zhong Q; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    J Med Chem; 2015 Jun; 58(11):4713-26. PubMed ID: 25961334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin against Prostate Cancer: Current Evidence.
    Termini D; Den Hartogh DJ; Jaglanian A; Tsiani E
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33182828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-based anti-prostate cancer agents.
    Chen QH
    Anticancer Agents Med Chem; 2015; 15(2):138-56. PubMed ID: 25594891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.
    Zhang X; Wang R; Perez GR; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem; 2016 Oct; 24(19):4692-4700. PubMed ID: 27543391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
    Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.